In the article titled “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first. The corrected author list and affiliations are shown above.
Special Issue
Corrigendum | Open AccessSuccesses and Challenges for Diagnosis and Therapy of Acute Leukemia
View this Special IssueCorrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
Received07 Aug 2020
Accepted07 Aug 2020
Published04 Sept 2020
References
A. Vitkevičienė, G. Skiauterytė, A. Žučenka et al., “HDAC and HMT inhibitors in combination with conventional therapy: a Novel treatment option for acute promyelocytic leukemia,” Journal of Oncology, vol. 2019, Article ID 6179573, 11 pages, 2019.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2020 Aida Vitkevičienė et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.